Search
for

    GlossaryPyrilutamide (KX-826)

    topical treatment blocking androgen receptors to combat hair loss

    Pyrilutamide, also known as KX-826, is a topical non-steroidal anti-androgen being developed for the treatment of androgenetic alopecia (pattern hair loss). It works by blocking androgen receptors in hair follicles, which can help reduce hair loss and potentially promote hair regrowth.

    Learn

    1 / 1 results

      learn Pyrilutamide

      highly targeted anti-androgen that might have minimal systemic effects

    Research

    5 / 130 results

    Community Join

    5 / 233 results

      community Is .5% kx-826 worthless? Koshine vs RU

      in Research/Science  3 upvotes 3 weeks ago
      Kx-826 at 0.5% shows limited effectiveness for hair loss, while 1% is more promising but expensive. RU58841 is considered a more feasible option until 1% kx-826 becomes affordable.

      community KX-826 seems to be working for me

      in Product  1 upvotes 2 months ago
      KX-826 stopped hair loss for the user after stopping finasteride due to mild side effects. The user experienced mild headaches initially with KX-826, which resolved after a few days.

      community Anyone have any KX-826 results yet?

      in Product  14 upvotes 4 months ago
      KX-826 users report increased shedding, with some experiencing more shedding at higher concentrations. Users are discussing where to purchase the product.

      community KX-826: Long-Term Safety Results are out!

      in Research/Science  159 upvotes 4 months ago
      KX-826 initially improves hair growth but declines after 24 weeks, with mild itching as a side effect. Combining it with minoxidil and finasteride may improve results, but long-term effectiveness is uncertain.

      community KX-826 Pyrilutamide1% coming soon

      in Update  152 upvotes 6 months ago
      KX-826 Pyrilutamide 1% is launching soon, and users are discussing its potential benefits and drawbacks compared to other treatments like Minoxidil and finasteride. Some users are skeptical about its effectiveness, while others are hopeful it will be a safer alternative.